Receptive CPE Activities
Medication Reconciliation and Review in the Community : Experience from District Health Centre and Nursing Home
29th Hong Kong Medical Forum 2025 - Enhancing Medical Care through Collaboration and Innovation (Day 1 only)
29th Hong Kong Medical Forum 2025 - Enhancing Medical Care through Collaboration and Innovation (Day 2 only)
Leqembi ( Lecanemab ): breakthrough for Alzheimer’s Disease (AD): for Mild Cognitive Impairment (MCI) or early AD dementia